GTBP Stock Analysis: Buy, Sell, or Hold?
GTBP - GT Biopharma Inc. Common Stock
$0.46
-0.03 (-6.03%)
▼
5d:
+4.11%
30d:
+5.45%
90d:
-2.34%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When GTBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GTBP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GTBP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GTBP is currently trading at $0.46, which is considered slightly high relative to its 30-day fair value range of $0.41 to $0.48.
Technical Outlook: Technically, GTBP is in a downtrend. Immediate support is located at $0.37, while resistance sits at $0.49. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: GTBP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+507.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GTBP is in a downtrend. Immediate support is located at $0.37, while resistance sits at $0.49. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: GTBP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+507.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.41 -
$0.48
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 507.5% below Wall St target ($3.00)
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.48
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$0.50
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.83
Wall Street Target
$3.00
(+507.5%)
Share & Embed Analysis
Last updated: June 24, 2026 2:04 PM ET
Data refreshes hourly during market hours. Next update: 3:04 PM
Data refreshes hourly during market hours. Next update: 3:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GTBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 60 BUY |
